A Brooklyn federal judge on Wednesday rejected the latest request from several Platinum Partners LLP executives to dismiss a criminal fraud case against them, saying there wasn't enough proof to support the idea that prosecutors hid evidence or fabricated threats to witnesses.
King & Spalding LLP is expanding its government-related practice groups with the addition this week of a former Georgia state legislator who recently helped screen judge candidates in filling vacancies on the bench, and a veteran U.S. Department of Justice prosecutor who sent corrupt judges to prison.
A pathologist fielded questions in a California courtroom Wednesday from jurors considering whether Johnson & Johnson baby powder contained asbestos that caused a dying woman’s cancer, explaining that the asbestos amounts found in the woman’s lung tissue and lymph nodes were too high to have come from ambient air.
The Missouri Supreme Court has granted Johnson & Johnson's last-minute bid to pause a trial on claims that asbestos in the pharmaceutical giant's talcum powder products gave 13 women ovarian cancer, issuing a stay days before jury selection was scheduled to begin in St. Louis.
A Michigan appellate court said Tuesday improper jury instructions warrant a new trial in a suit accusing a firm of failing to pay a solo practitioner a $680,000 fee as part of a referral agreement in an auto collision suit that ended in a $10.2 million award.
The Missouri Supreme Court on Tuesday affirmed a jury's $28.9 million award in a suit accusing a hospital of failing to diagnose a woman's rare genetic disorder, which caused permanent brain damage and paralysis, and ruled that postjudgment interest was improperly denied by the trial judge.
A Manhattan jury mulled Wednesday whether to award entrepreneur Shmuel "Sam" Sherman damages after his company accused a rival of poaching what Sherman calls revolutionary software that allows resale brokers to easily reprice inventory in the multibillion-dollar market for sports and entertainment tickets.
Two boat companies that had fought for years over claims they infringed each other's trademarks found out from a Delaware federal jury Wednesday that their entire fight was for nothing — no one's trademarks were infringed at all.
The ex-husband of a former Ariad Pharmaceuticals executive was sentenced to 18 months in prison Wednesday for insider trades he made based on meetings his then-wife had with the U.S. Food and Drug Administration about the company's cancer drug.
Counsel for the widow of a manufacturing plant worker who died of mesothelioma told a New Jersey jury during closing arguments Wednesday that asbestos supplier Union Carbide Corp. caused the "worst pain and suffering" possible and should be forced to pay damages to match.
The day before hundreds of potential jurors descend on a Boston courtroom for a closely watched criminal case accusing former Insys Therapeutics Inc. executives of bribing doctors to prescribe opioids, attorneys sparred Wednesday over what patients who took the drug can say during the 14-week trial.
Three former Barclays PLC traders were part of a conspiracy to cheat the financial system that “tainted” the integrity of a key interest rate benchmark used to price trillions of dollars of financial products, prosecutors told a London jury on Wednesday.
A Manhattan federal judge on Tuesday spared the founder of hedge fund manager Weston Capital Asset Management from prison over his role in a multimillion-dollar investment fraud scheme after the government cited his crucial cooperation in prosecutions that brought down film producer David Bergstein and serial fraudster Jason Galanis.
A University of California, Berkeley economics professor testified for the Federal Trade Commission on Tuesday that Qualcomm's standard-essential patent royalties serve as a competition-killing "naked tax" on its modem chips, comparing the practice to software bundling that got Microsoft in trouble with the feds 20 years ago.
The Patent Trial and Appeal Board will review an IBM Corp. e-commerce patent challenged by a group of travel websites, rejecting Tuesday the argument that it should deny the petition in light of a recent jury verdict against Groupon Inc. in a $57 million infringement dispute.
Medical device maker Greatbatch Ltd. received a $22 million damages award Monday following a six-day trial in Delaware federal court over three pacemaker technology patents infringed by AVX Corp., replacing a 2016 jury decision that awarded it $37.5 million.
A Minnesota appeals court on Monday affirmed a $4.7 million verdict for a driver who was seriously hurt when a rock from a construction company’s truck smashed into his vehicle, and said the lower court needs to consider putting punitive damages back on the table.
The Eleventh Circuit on Tuesday vacated an injury award in a suit blaming the federal government for injuries a NASA civilian employee suffered in an auto collision due to a U.S. Army base security guard’s alleged negligence, saying the government is immune to liability under the Federal Tort Claims Act.
Westinghouse Air Brake Technologies Corp. on Tuesday called a battery of Siemens Mobility Inc. patent infringement claims "desperate" gambits by a latecomer to the U.S. rail safety market, during opening statements in Delaware for a nine-day $8.3 million federal jury trial.
A state judge in Pittsburgh awarded “quadruple damages” against Ameriprise Financial Inc. based on an erroneous reading of Pennsylvania law and wrongly handed out attorneys’ fees that had ballooned during appeal, the company told a state Superior Court panel Tuesday in a life insurance overpayment dispute.
As it appears the federal government shutdown could continue for some time, attorneys with Troutman Sanders LLP discuss its effect on the regulatory and litigation docket for consumer-facing companies.
Contrary to what the New York City Bar Association concluded in an ethics opinion last year, lawyer-directed nonrecourse commercial litigation funding does not violate New York rules on sharing fees with nonlawyers, say Peter Jarvis and Trisha Thompson of Holland & Knight LLP.
In U.S. Commodity Futures Trading Commission v. Wilson, a New York federal court properly relied on 30 years of precedent to overturn the CFTC's broad new theory of manipulative intent, says Chad Silverman of Skadden Arps Slate Meagher & Flom LLP.
Law firms should redesign the vetting process for lateral candidates so it directly addresses sexual harassment and assault issues, says Howard Rosenberg of Decipher.
The U.S. Department of Justice Criminal Division's 22-page report on the Fraud Section's accomplishments in 2018 provides important hints at what the future holds for individuals and entities whose activities come within the section’s broad reach, say Kevin Muhlendorf and Madeline Cohen of Wiley Rein LLP.
In this monthly series, Amanda Brady of Major Lindsey & Africa interviews management from top law firms about the increasingly competitive business environment. Here we feature Sadie Baron, chief marketing officer at Reed Smith LLP.
2018 marked another interesting year in the shifting landscape of pharmaceutical drug preemption, with important cases concerning newly acquired information, generic drugs, innovator liability, clear evidence, serious adverse events and marketing claims, says Connor G. Sheehan of Dunn Sheehan LLP.
A civil defendant implicated in a criminal investigation faces a difficult choice: Defend the civil case and waive the Fifth Amendment right against self-incrimination, or invoke the privilege, but risk hobbling the defense of the civil case, say Paul Chan and Fanxi Wang of Bird Marella Boxer Wolpert Nessim Drooks Lincenberg & Rhow PC.
The rise of remote work capabilities and advances in technology are making flexible, freelance legal work a more accessible career option for corporate attorneys, say Elizabeth Black and Sara Eng of InCloudCounsel.
While several proposed changes to multidistrict litigation procedures may be warranted and appropriate, consideration should be given to a modest modification of the judicial selection process, says Doug Smith of Kirkland & Ellis LLP.